Biomedical Innovation

Jul 3, 2024 | bmcpublichealth.biomedcentral.com | Sun Yat-sen |Biomedical Innovation

We chose two hospitals located in southern and northern China as the study site, that differ greatly in terms of climate and economic levels. One is a large teaching hospital located in Shenzhen, a megacity in southern China (22°38′N, 114°05′E). Shenzhen has the third-largest GDP in China with a permanent resident population of 17.56 million (according to 2020 statistics).

Jul 3, 2024 | academic.oup.com | Biomedical Innovation

Endometriosis and adenomyosis are associated with chronic pelvic pain, painful menses, and infertility. Determining treatment efficacy is reliant on patient reported outcomes (PRO) which are sensitive to response style effects and may lag changes in underlying pathology. Availability of biomarkers measuring lesion burden could accelerate the development of therapies treating disease rather than managing symptoms.

Mar 23, 2024 | onlinelibrary.wiley.com | Biomedical Innovation |Jim Manavis |Akihiro Yamanaka |Alisha Braun

Little is known about the early stages of Parkinson's disease and research has shown the orexin system has a potential role in contributing to non-motor symptoms of the disease. This review discusses the most recent evidence on orexin in Parkinson's disease and animal models of the disease. This allows researchers to understand the role of orexin in the disease and to identify gaps in research to further study these areas.

Jan 9, 2024 | bmcnutr.biomedcentral.com | Biomedical Innovation

ReferencesCardoso DA, Moreira ASB, de Oliveira GMM, Raggio Luiz R, Rosa G, A COCONUT EXTRA VIRGIN OIL-RICH DIET INCREASES HDL CHOLESTEROL, AND DECREASES WAIST CIRCUMFERENCE AND BODY MASS IN CORONARY ARTERY DISEASE PATIENTS. Nutr Hosp [Internet]. 2015 Nov 1 [cited 2019 Jul 6];32(5):2144–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26545671. Khaw Ktee, Sharp SJ, Finikarides L, Afzal I, Lentjes M, Luben R et al.

Oct 4, 2023 | cardiab.biomedcentral.com | Miguel Ángel |Biomedical Innovation

The UK Biobank cohort is a multicenter prospective population-based study in the United Kingdom (England, Wales, and Scotland) with around 500,000 participants aged 40–69 years at the time of enrollment. Study methods have been reported elsewhere [15, 16]. Briefly, participants were recruited from 2006 to 2010 in twenty-two assessment centers.